Anthony Quartararo

Anthony Quartararo is a Scientist at FogPharma since September 2020, previously serving as a Research Assistant at the Massachusetts Institute of Technology from August 2014 to September 2020. At MIT, Anthony developed a platform for the discovery of non-natural peptides that inhibit protein-protein interactions and characterized high-affinity binding reagents for various protein targets, including the oncogenic ubiquitin ligase MDM2. Earlier, Anthony worked as an Undergraduate Research Assistant at the University of Florida from January 2012 to August 2014. Anthony holds a Doctor of Philosophy in Chemistry from the Massachusetts Institute of Technology (2014-2020) and two Bachelor of Science degrees in Chemistry and Microbiology from the University of Florida (2011-2014).